Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Methods of applying the 1994 case definition of chronic fatigue syndrome - impact on classification and observed illness characteristics.

Unger ER, Lin JM, Tian H, Gurbaxani BM, Boneva RS, Jones JF.

Popul Health Metr. 2016 Mar 12;14:5. doi: 10.1186/s12963-016-0077-1. eCollection 2016.

2.

Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine types.

Panicker G, Rajbhandari I, Gurbaxani BM, Querec TD, Unger ER.

J Immunol Methods. 2015 Feb;417:107-14. doi: 10.1016/j.jim.2014.12.013. Epub 2014 Dec 30.

3.

Randomization modeling to ascertain clustering patterns of human papillomavirus types detected in cervicovaginal samples in the United States.

Querec TD, Gurbaxani BM, Unger ER.

PLoS One. 2013 Dec 18;8(12):e82761. doi: 10.1371/journal.pone.0082761. eCollection 2013.

4.

Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?

Gurbaxani B, Dostalek M, Gardner I.

Mol Immunol. 2013 Dec;56(4):660-74. doi: 10.1016/j.molimm.2013.05.008. Epub 2013 Aug 2. Review.

PMID:
23917469
5.

Multiscale analysis of heart rate variability in non-stationary environments.

Gao J, Gurbaxani BM, Hu J, Heilman KJ, Emanuele Ii VA, Lewis GF, Davila M, Unger ER, Lin JM.

Front Physiol. 2013 May 30;4:119. doi: 10.3389/fphys.2013.00119. eCollection 2013.

6.

Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.

Dostalek M, Gardner I, Gurbaxani BM, Rose RH, Chetty M.

Clin Pharmacokinet. 2013 Feb;52(2):83-124. doi: 10.1007/s40262-012-0027-4. Review.

PMID:
23299465
7.

Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approach.

Emanuele VA 2nd, Panicker G, Gurbaxani BM, Lin JM, Unger ER.

PLoS One. 2012;7(11):e48103. doi: 10.1371/journal.pone.0048103. Epub 2012 Nov 12.

8.

Entropies of negative incomes, Pareto-distributed loss, and financial crises.

Gao J, Hu J, Mao X, Zhou M, Gurbaxani B, Lin J.

PLoS One. 2011;6(10):e25053. doi: 10.1371/journal.pone.0025053. Epub 2011 Oct 3.

9.

Quadratic variance models for adaptively preprocessing SELDI-TOF mass spectrometry data.

Emanuele VA 2nd, Gurbaxani BM.

BMC Bioinformatics. 2010 Oct 13;11:512. doi: 10.1186/1471-2105-11-512.

10.

Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease association.

Falkenberg VR, Gurbaxani BM, Unger ER, Rajeevan MS.

Neuromolecular Med. 2011 Mar;13(1):66-76. doi: 10.1007/s12017-010-8138-2. Epub 2010 Oct 13.

11.

Benchmarking currently available SELDI-TOF MS preprocessing techniques.

Emanuele VA 2nd, Gurbaxani BM.

Proteomics. 2009 Apr;9(7):1754-62. doi: 10.1002/pmic.200701171.

PMID:
19294696
12.

Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls.

Nater UM, Maloney E, Boneva RS, Gurbaxani BM, Lin JM, Jones JF, Reeves WC, Heim C.

J Clin Endocrinol Metab. 2008 Mar;93(3):703-9. Epub 2007 Dec 26.

PMID:
18160468
13.

Perception versus polysomnographic assessment of sleep in CFS and non-fatigued control subjects: results from a population-based study.

Majer M, Jones JF, Unger ER, Youngblood LS, Decker MJ, Gurbaxani B, Heim C, Reeves WC.

BMC Neurol. 2007 Dec 5;7:40.

14.

Incomplete assembly of IgA2m(2) in Chinese hamster ovary cells.

Chintalacharuvu KR, Gurbaxani B, Morrison SL.

Mol Immunol. 2007 Jul;44(13):3445-52. Epub 2007 Apr 27.

PMID:
17467056
15.

Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistability.

Gupta S, Aslakson E, Gurbaxani BM, Vernon SD.

Theor Biol Med Model. 2007 Feb 14;4:8.

16.

Mathematical modeling as accounting: predicting the fate of serum proteins and therapeutic monoclonal antibodies.

Gurbaxani B.

Clin Immunol. 2007 Feb;122(2):121-4. Epub 2006 Nov 22. Review.

PMID:
17126081
17.

Allostatic load is associated with symptoms in chronic fatigue syndrome patients.

Goertzel BN, Pennachin C, de Souza Coelho L, Maloney EM, Jones JF, Gurbaxani B.

Pharmacogenomics. 2006 Apr;7(3):485-94.

PMID:
16610958
18.

Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome.

Goertzel BN, Pennachin C, de Souza Coelho L, Gurbaxani B, Maloney EM, Jones JF.

Pharmacogenomics. 2006 Apr;7(3):475-83.

PMID:
16610957
19.

Chronic fatigue syndrome and high allostatic load.

Maloney EM, Gurbaxani BM, Jones JF, de Souza Coelho L, Pennachin C, Goertzel BN.

Pharmacogenomics. 2006 Apr;7(3):467-73.

PMID:
16610956
20.

Linear data mining the Wichita clinical matrix suggests sleep and allostatic load involvement in chronic fatigue syndrome.

Gurbaxani BM, Jones JF, Goertzel BN, Maloney EM.

Pharmacogenomics. 2006 Apr;7(3):455-65.

PMID:
16610955
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk